Literature DB >> 3292583

Hypercalcemia of malignancy revisited.

G R Mundy1.   

Abstract

Entities:  

Mesh：

Year:  1988        PMID： 3292583      PMCID： PMC303467          DOI： 10.1172/JCI113555

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  45 in total

1.  Tumor products and the hypercalcemia of malignancy.

Authors:  G R Mundy; K J Ibbotson; S M D'Souza
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

2.  Purification and partial sequence of human osteoclast-activating factor: identity with interleukin 1 beta.

Authors:  F E Dewhirst; P P Stashenko; J E Mole; T Tsurumachi
Journal:  J Immunol       Date:  1985-10       Impact factor: 5.422

3.  Biochemical evaluation of patients with cancer-associated hypercalcemia: evidence for humoral and nonhumoral groups.

Authors:  A F Stewart; R Horst; L J Deftos; E C Cadman; R Lang; A E Broadus
Journal:  N Engl J Med       Date:  1980-12-11       Impact factor: 91.245

4.  Hypercalcemia associated with increased serum calcitriol levels in three patients with lymphoma.

Authors:  N A Breslau; J L McGuire; J E Zerwekh; E P Frenkel; C Y Pak
Journal:  Ann Intern Med       Date:  1984-01       Impact factor: 25.391

5.  Direct resorption of bone by human breast cancer cells in vitro.

Authors:  G Eilon; G R Mundy
Journal:  Nature       Date:  1978-12-14       Impact factor: 49.962

6.  Estrogens and antiestrogens stimulate release of bone resorbing activity by cultured human breast cancer cells.

Authors:  A Valentin-Opran; G Eilon; S Saez; G R Mundy
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

7.  An interleukin 1 like factor stimulates bone resorption in vitro.

Authors:  M Gowen; D D Wood; E J Ihrie; M K McGuire; R G Russell
Journal:  Nature       Date:  1983 Nov 24-30       Impact factor: 49.962

8.  Factors associated with humoral hypercalcemia of malignancy stimulate adenylate cyclase in osteoblastic cells.

Authors:  S B Rodan; K L Insogna; A M Vignery; A F Stewart; A E Broadus; S M D'Souza; D R Bertolini; G R Mundy; G A Rodan
Journal:  J Clin Invest       Date:  1983-10       Impact factor: 14.808

9.  Absence of parathyroid hormone messenger RNA in nonparathyroid tumors associated with hypercalcemia.

Authors:  E L Simpson; G R Mundy; S M D'Souza; K J Ibbotson; R Bockman; J W Jacobs
Journal:  N Engl J Med       Date:  1983-08-11       Impact factor: 91.245

Review 10.  The hypercalcemia of malignancy: pathogenesis and management.

Authors:  G R Mundy; T J Martin
Journal:  Metabolism       Date:  1982-12       Impact factor: 8.694
View more
  22 in total

1.  Neurochemical and cellular reorganization of the spinal cord in a murine model of bone cancer pain.

Authors:  M J Schwei; P Honore; S D Rogers; J L Salak-Johnson; M P Finke; M L Ramnaraine; D R Clohisy; P W Mantyh
Journal:  J Neurosci       Date:  1999-12-15       Impact factor: 6.167

Review 2.  1,25-Dihydroxyvitamin D-related hypercalcemia in lymphoma: two case reports.

Authors:  J P Devogelaer; M Lambert; B Boland; C Godfraind; H Noel; C Nagant de Deuxchaisnes
Journal:  Clin Rheumatol       Date:  1990-09       Impact factor: 2.980

Review 3.  Assessment of renal and skeletal components of hypercalcemia.

Authors:  D J Hosking
Journal:  Calcif Tissue Int       Date:  1990       Impact factor: 4.333

Review 4.  Malignant bone pain: pathophysiology and treatments.

Authors:  C Ripamonti; F Fulfaro
Journal:  Curr Rev Pain       Date:  2000

5.  Retroperitoneal myxoid liposarcoma presenting with hypercalcaemia.

Authors:  P A Cross; B A Enoch
Journal:  J Clin Pathol       Date:  1989-03       Impact factor: 3.411

6.  Increased prevalence of primary hyperparathyroidism in treated breast cancer.

Authors:  P Fierabracci; A Pinchera; P Miccoli; P F Conte; E Vignali; M Zaccagnini; C Marcocci; C Giani
Journal:  J Endocrinol Invest       Date:  2001-05       Impact factor: 4.256

7.  Production of parathyroid hormone and parathyroid-hormone-related protein by breast cancer cells in culture.

Authors:  G Francini; E Maioli; R Petrioli; P Paffetti; S Gonnelli; A Aquino
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

8.  Parathyroid hormone-related protein: primary osteolytic factor produced by breast tumor cells in vitro?

Authors:  A Tabuenca; S Mohan; C A Garberoglio; P I Borgen; T Rosol; T A Linkhart
Journal:  World J Surg       Date:  1995 Mar-Apr       Impact factor: 3.352

9.  Parathyroid hormone related protein and hypercalcaemia in breast cancer.

Authors:  N J Bundred; W A Ratcliffe; R A Walker; S Coley; J M Morrison; J G Ratcliffe
Journal:  BMJ       Date:  1991-12-14

Review 10.  Drugs used in the treatment of metabolic bone disease. Clinical pharmacology and therapeutic use.

Authors:  S Patel; A R Lyons; D J Hosking
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.